The 4th Annual Biopharma China Congress 2014
Time:April 16-17, 2014
Country&Region:Shanghai, Shanghai, China Mainland
Venue:Shanghai
Organizer:JFPS Group
Based on the great success of our past events in Life Science Industry, namely Biopharma & VacTech China Congress, "the 4th Annual Biopharma China Congress 2014" is organized now aiming at continuously creating the best platform for biopharma professionals in China.
This year's event will be discussing the hottest issues with 5 chapters focusing on Vaccine Technology, Antibody, Protein Drugs, Cell Culture and Biopharma. More than 40 senior speakers from the leading companies will be invited to share their best practice in the field of New Generation Vaccine, Adjuvant, Optimization of Cell Strain & Protein Expression, Cell Culture Development, Large Scale Manufacturing, Biosimilar, and Explanation to Newest Regulation & Marketing Development. 16 networking slots with more than 560 minutes will be provided to the attending companies to look into future cross-boarder growth opportunities and reach for new strategic focus!
|
Day One
|
|
Stream One (Vaccine Technology)
|
Stream Two (Antibody)
|
|
Trends and R & D Progress
|
Market Analysis
|
|
• Challenges & Opportunities of Vaccine in China
|
• Asian mAb Market Analysis
|
|
• Progress in Influenza Vaccine R & D
|
• New Antibody Drugs R & D
|
|
• The Development of Combined Vaccine
|
• Development & Outlook on Biosimilar Market
|
|
• DNA Vaccine & DNA Technology
|
• New Process in Cure Antibody Drugs
|
|
Production Technology
|
New Tech
|
|
• Optimization of Vaccine Production
|
• Chimeric Antibody R & D
|
|
• Improvement of Viral Expression
|
• The Development of Human Monoclonal Antibody
|
|
• Contract Manufacturing Strategies
|
• The Multi Targeted Therapeutic Effects
|
|
• Downstream Purification
|
• Key Technology of High Yield for Recombinant Protein / Antibody Drugs
|
|
Day Two
|
|
Stream One (Cell Culture)
|
Stream Two (Biopharma)
|
|
Opportunities & Innovation
|
Explanation of Policy & Regulations
|
|
• The Trend and Outlook of Cell Culture
|
• Trends, Challenges & Opportunities
|
|
• 3D Cell Culture
|
• Global Trends of International Vaccine R & D
|
|
• Primary Cell in Cell Culture
|
• Biological drugs in China, U.S. And Europe reporting and technical assessment
|
|
• The Construction of Cell Line
|
• Markets Globalization & Manufacturing Localization
|
|
Technology Optimization
|
Independent R & D and International Cooperation
|
|
• Screening of Cell Strain
|
• International Corporation & Technology Transfer
|
|
• Medium Optimization
|
• Recombinant Protein Drug R & D
|
|
• Challenge and Opportunities of Cell Line and Media Development
|
• Independent Research & CRO Selection
|
|
• Optimization of Protein Expression
|
• Biopharma CRO & CMO in China
|
More information：http://www.biopharma-china.com/
Contact：Eva Zhang
Tel：+86-21-51720000-125
E-mail：eva.zhang@jfpsgroup.com.cn
About JFPS Group
JFPS Group is the leading business performance enhancement company with partners across the globe. As a world-class business intelligence provider, JFPS Group provides business executives with knowledge, skills and business opportunities through conferences, professional training, in-house training, consulting and trade shows
Pharma Sources Insight January 2025
